Novel radiotherapy schedules aid recovery of normal tissues after treatment.
Fowler
Jack F
JF
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D015415:Biomarkers / Q000378:metabolism; D006528:Carcinoma, Hepatocellular / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D049109:Cell Proliferation / Q000187:drug effects / Q000528:radiation effects; D019583:Dose Fractionation, Radiation; D019008:Drug Resistance, Neoplasm; D005838:Genotype; D006258:Head and Neck Neoplasms / Q000378:metabolism / Q000473:pathology / Q000532:radiotherapy*; D006801:Humans; D008113:Liver Neoplasms / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D014411:Neoplastic Stem Cells / Q000187:drug effects / Q000378:metabolism / Q000473:pathology / Q000528:radiation effects*; D010641:Phenotype; D011832:Radiation Injuries / Q000209:etiology / Q000517:prevention & control; D011836:Radiation Tolerance; D011878:Radiotherapy / Q000009:adverse effects; D013997:Time Factors; D016896:Treatment Outcome
D000970:Antineoplastic Agents; D015415:Biomarkers